Annual Drug Patent Expirations for JUBLIA
Jublia is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for JUBLIA.
This drug has seventy-seven patent family members in twenty-four countries.
The generic ingredient in JUBLIA is efinaconazole. One supplier is listed for this compound. Additional details are available on the efinaconazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
